Taking metronidazole alongside semaglutide: what the evidence says

No direct drug-drug interaction between metronidazole and semaglutide is currently listed in the UK's standard prescribing references, but both medicines share a gastrointestinal side-effect profile.
Semaglutide slows gastric emptying, which may theoretically affect how quickly some oral medicines are absorbed; your prescriber or pharmacist can advise on timing.
Metronidazole interacts with alcohol, producing nausea and flushing, a reaction that may feel worse if you already have GLP-1-related nausea.
Any new or worsening symptoms while taking both medicines should be reported to your prescriber promptly; do not adjust your semaglutide dose without clinical guidance.

If you have been prescribed metronidazole while you are taking semaglutide for weight management, the most important thing to know is that no direct pharmacokinetic interaction between the two medicines has been formally documented in clinical studies. That said, both drugs can independently affect the gut, and the combination deserves a clear-headed look before your next dose. Semaglutide is a prescription-only GLP-1 receptor agonist, available in the UK as Wegovy, which slows gastric emptying and reduces appetite as part of a clinically supervised weight-management plan. Metronidazole is an antibiotic and antiprotozoal medicine prescribed for infections including bacterial vaginosis, dental abscesses and certain gut infections. Because both can cause gastrointestinal side effects, understanding how they sit together — and when to flag anything to your prescriber — is genuinely useful.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How to manage metronidazole alongside your semaglutide course, step by step

Step 1: understand what each medicine is doing, and where they overlap

Semaglutide works by activating the GLP-1 receptor, a pathway that reduces appetite, slows the rate at which food leaves the stomach and improves blood-sugar regulation. The semaglutide information page on the NHS sets this out clearly, and the mechanism is well established from the STEP trial programme. Metronidazole targets anaerobic bacteria and certain parasites; it is typically prescribed for a short course of five to seven days.

Where the two medicines share territory is the gut. Nausea, stomach discomfort and loose stools are recognised side effects of metronidazole. They are also among the most commonly reported effects of semaglutide, particularly in the first weeks of treatment or after a dose increase. Running both at the same time does not produce a new or unique interaction, but it can mean that ordinary antibiotic side effects feel more pronounced than they otherwise would.

One practical note: metronidazole's well-known interaction with alcohol is worth keeping front of mind. Drinking alcohol while taking metronidazole can cause a disulfiram-like reaction, flushing, rapid heart rate and intensified nausea. If your GLP-1 treatment has already made you sensitive to nausea, this reaction can feel more distressing. Avoiding alcohol for the duration of the metronidazole course, and for 48 hours after the last tablet, is standard advice from the NHS regardless of whether you are taking semaglutide. It is also worth knowing that some men using semaglutide have questions about sexual health, and our overview of semaglutide and erectile dysfunction covers what the current evidence says on that topic.

Step 2: consider the gastric-emptying question for oral medicines generally

One area where semaglutide does require careful thought involves oral medicines taken at the same time. Because semaglutide slows gastric emptying, the absorption of some oral drugs may be altered. The prescribing reference for semaglutide notes this as a theoretical consideration rather than a contraindication for most medicines, but it is a real mechanism.

For metronidazole specifically, no study has measured whether semaglutide changes its pharmacokinetics in a clinically meaningful way. The available evidence does not suggest a problem, and metronidazole is absorbed relatively rapidly even when gastric emptying is slower. What this step is really about is building the habit of flagging all medicines (prescription, over-the-counter and supplements) to your prescriber whenever you start something new alongside semaglutide. That conversation takes less than a minute and rules out the things that do matter.

If you find the gastrointestinal effects of the combination particularly difficult to manage (say, you started metronidazole the week you also moved to a higher semaglutide dose) it is worth talking through timing with whoever prescribed it. Some patients find taking metronidazole with or just after food (where permitted by the prescribing instructions) helps to reduce stomach upset. Always check the patient information leaflet for the antibiotic before adjusting when you take it.

Step 3: recognise symptoms that need prompt attention

Most people taking metronidazole alongside Wegovy or another semaglutide preparation will experience nothing beyond mild, manageable stomach upset. Knowing which symptoms go beyond the ordinary is the practical skill worth acquiring.

Severe or persistent abdominal pain, particularly if it spreads to the back, should not be attributed to a mild interaction and dismissed. The MHRA has highlighted acute pancreatitis as an infrequent but serious risk with GLP-1 receptor agonists; the January 2026 Drug Safety Update specifically asks patients and clinicians to treat persistent, severe stomach pain as a reason for urgent medical review. Metronidazole is not associated with pancreatitis, so if this symptom appears during your antibiotic course, semaglutide should remain in the frame as the relevant medicine to discuss with a clinician. You can report suspected side effects through the MHRA's Yellow Card scheme, which helps regulators track signals across large numbers of patients.

Signs of a serious allergic reaction (facial swelling, difficulty breathing, a widespread rash) are rare but warrant a 999 call with any medicine. Worsening confusion, unusual mouth tingling or peripheral numbness are recognised, if uncommon, side effects of metronidazole worth mentioning to your GP. If you are at all uncertain about symptoms, the nume support team is available seven days a week for aftercare queries.

Step 4: keep your prescriber in the picture

The practical close to this topic is simpler than the pharmacology suggests. Tell your prescriber or community pharmacist that you are taking semaglutide whenever a new medicine is prescribed. This is not about panic; it is about giving the clinician reviewing your case the full picture. The frequently asked questions on medication combinations come up regularly enough that it is worth treating this as a standard step rather than an afterthought.

At nume, every repeat order of Wegovy is clinically reviewed by a GPhC-registered prescriber before it is dispensed, the consultation is not a formality. If you are mid-antibiotic course and your next semaglutide pen is due, that review is a natural moment to mention it. People sometimes wonder whether to delay an order around a course of antibiotics or a short holiday; in most cases, a brief antibiotic course does not change your semaglutide schedule, but confirming that with a prescriber is always the right move. Our clinical team and the wider prescribing staff are the people best placed to give you a personalised answer.

If you want to read more about semaglutide's side-effect profile and how the medicine works across the weight-management journey, the semaglutide overview covers the evidence in detail. For a broader look at weight-loss treatment options available in the UK, including how semaglutide compares with other licensed approaches, that page sets out the landscape clearly. You might also find the guide to omeprazole and semaglutide useful if you take a proton pump inhibitor alongside your weekly injection, as it addresses a similar question about concurrent medicines.

If you are not yet on treatment and are considering Wegovy, the starting point is a free clinical consultation. A prescriber will review your full medicine list, including any recurring prescriptions like antibiotics, before recommending anything. Start your free consultation and have those details to hand when you fill in the form.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions